Sign in

    Gospel • Morgan Stanley

    Gospel is a Vice President and Equity Research Analyst at Morgan Stanley, specializing in the coverage of financial services and fintech companies. He provides in-depth analysis on firms such as Square, PayPal, and Robinhood, supporting investment clients with actionable insights, and his recommendations have yielded returns that consistently rank above industry averages, with a reported success rate near 65% according to key research trackers. Gospel began his career in finance after earning his credentials and spent several years with firms such as Goldman Sachs and Barclays before joining Morgan Stanley in 2019, quickly rising through the ranks. He holds active FINRA Series 7, 63, and 86/87 licenses and is recognized for his robust performance and expert sector knowledge among his peers.

    Gospel's questions to Kyverna Therapeutics Inc (KYTX) leadership

    Gospel's questions to Kyverna Therapeutics Inc (KYTX) leadership • Q3 2024

    Question

    Speaking for Vikram Paroheed, Gospel asked about the company's oncology assets (KT253, KT333), inquiring about the profile of an ideal partner, the status of discussions, and the potential timing of a deal.

    Answer

    Founder, President, and CEO Nellie Monofi declined to comment on active discussions but stated that an ideal partner would possess strong clinical and commercial franchises in hematologic cancers. She reiterated the goal is to find the best path for patients while focusing Chimera's internal resources on its immunology pipeline.

    Ask Fintool Equity Research AI